Montelukast Teva (Montelukast Sodium)

Montelukast selectively blocks the cysteinyl leukotriene receptor CysLT1 on airway smooth‑muscle cells and inflammatory cells. By antagonizing this receptor, it prevents leukotriene D4‑mediated bronchoconstriction, mucus secretion and vascular permeability, thereby reducing airway inflammation and allergic responses.

The specific dose and dosing schedule are determined by the prescribing healthcare professional based on the patient’s age, indication and clinical response. Montelukast is typically taken once daily in the evening, but the exact regimen should follow the prescriber’s instructions.

Safety data for montelukast in pregnancy are limited, and the product is classified as pregnancy category unknown. It should only be used if the potential benefit justifies any potential risk to the fetus. Caution is also advised during breastfeeding, as the drug is excreted in breast milk; a healthcare provider should evaluate the risk‑benefit balance.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Montelukast offers an oral, once‑daily alternative to inhaled corticosteroids and long‑acting β‑agonists for maintenance therapy. Unlike bronchodilators, it targets leukotriene‑mediated inflammation, which can be beneficial for patients with aspirin‑exacerbated respiratory disease or those who prefer oral therapy. It is often used as add‑on therapy rather than a sole replacement for inhaled steroids.

Montelukast Teva should be stored at ambient temperature below 25 °C, in the original packaging to protect it from moisture and light. Keep the product out of reach of children and do not use it after the expiry date printed on the label.

Montelukast Teva is taken orally, usually as a tablet, with or without food. The tablet should be swallowed whole with a glass of water. Dosing time is generally recommended in the evening to align with the nocturnal rise in leukotriene production, but patients should follow their prescriber’s directions.

Although uncommon, serious adverse reactions can include severe allergic responses such as anaphylaxis, neuropsychiatric events like depression or suicidal thoughts, and liver injury indicated by elevated enzymes or hepatitis. Patients should seek immediate medical attention if they experience rash, mood changes, jaundice or other concerning symptoms.

Montelukast is contraindicated in patients with known hypersensitivity to montelukast sodium or any of the tablet’s excipients. Caution is also advised for individuals with severe hepatic impairment, active psychiatric disorders, or those taking strong enzyme‑inducing drugs that may reduce efficacy. The prescriber should evaluate suitability before initiating therapy.